Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Second Edition BOGP (0)
United States (2)
Policy
Pharmaceutical, Biotech, Medical Device Company (0)
Health Technology Assessment (HTA) bodies
Shared purpose
Clinical study phase III